This inventor holds 2 USPTO granted patents. Top assignee: Shiseido Company, Limited. Active years: 1998-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yokohama, JP (1998)
- Kanagawa, JP (2000)
Company Filing History:
Years Active: 1998-2000
Title: Kentaro Adachi: Innovator in Radical Scavenger Development
Introduction
Kentaro Adachi is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmacology, particularly in the development of radical scavengers aimed at treating brain-related conditions. With a total of two patents to his name, Adachi's work is recognized for its potential impact on medical science.
Latest Patents
Adachi's latest patents include a phenylenediamine derivative radical scavenger and a pyrazolidine derivative radical scavenger. The phenylenediamine derivative is designed to inhibit lipid peroxidation, which can help in preventing brain infarction and brain edema. This compound comprises a phenylenediamine derivative or a pharmacologically acceptable salt, with specific structural components that enhance its effectiveness. The pyrazolidine derivative, on the other hand, also serves as a radical scavenger with antioxidant properties, aimed at providing similar protective effects against brain injuries.
Career Highlights
Kentaro Adachi is currently associated with Shiseido Company, Limited, where he continues to innovate in the field of radical scavengers. His work is characterized by a strong focus on developing compounds that can mitigate the effects of oxidative stress in the brain.
Collaborations
Adachi has collaborated with notable colleagues such as Chikao Nishino and Ryuhei Inada. Their combined expertise has contributed to the advancement of research in radical scavenger applications.
Conclusion
Kentaro Adachi's contributions to the field of pharmacology through his innovative patents highlight his commitment to improving medical treatments for brain-related conditions. His work continues to pave the way for future advancements in this critical area of health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
